Simon Vanstone – SiVan Consulting

Using analogs to support your strategy

Whenever analogs come up in pharma strategy, someone usually says: “But that situation wasn’t the same as ours.” In recent weeks, I’ve […]

Over recent months, I’ve been exploring novel diagnostic tools, with a particular focus on digital cognitive assessments. Along the way, I came […]

Every Project Plan Assumes People Don’t Leave. Reality Check: They Do. A few years ago, I took over a project that was […]

This past month, I have been immersed in obesity science, and one thing’s clear: not every pathway moves the scales. After dissecting […]

Intro Teams often fail not because of a lack of data, but because of research that confirms what they already believe. The […]

It has been a quiet summer on the post front with holidays and then a few active projects keeping us very but, […]

Intro At the end of May, Eli Lilly announced a $1 billion deal with Site One Therapeutics, a company developing a Nav1.8 […]

When you read the Pharma news sites and analysis on LinkedIn about drug patent cliffs, you might think pharmaceutical companies are sitting […]

With the sun out and a few projects wrapping up, I have enjoyed longer dog walks and catching up on new pharmaceutical […]

Introduction: Spotting the Threat You Didn’t Expect This week’s article is based on a project I completed earlier this year as part […]